President Donald Trump says Medicare will cover some GLP-1 drugs starting from July 1, potentially cutting costs to $50 a ...

Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It’s a notable shift for Medicare, which has long been barred from covering weight ...

Medicare drug changes in 2026 may raise costs, alter formularies, and add prior authorization. Learn how your medicines and ...

Learn who qualifies for Medicare’s GLP-1 Bridge, when $50 Wegovy and Zepbound access begins, and key rules beneficiaries need ...

GLP-1 weight loss drugs like Ozempic, Zepbound and Wegovy are the biggest contributor to rising prescription spending. And that will trigger co-payments to rise.

Millions rely on Medicare Part D, but many prescription drugs won't be covered in 2026. See which meds are excluded, why, and ...

WASHINGTON, DC: The Biden Administration announced a plan on November 26, 2024, to cover obesity drugs in Medicare and Medicaid. (Photo by Win McNamee/Getty Images) Last week, the Biden administration ...

High-demand obesity treatments will not be covered under the federal government’s Medicare program, it was announced Friday. The Centers for Medicare and Medicaid Services said late Friday that it ...

Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the popular weight-loss drugs ...

A blanket refusal to cover weight-loss medication like GLP-1s is no longer allowed under Washington state law, an appeals ...

President Donald Trump’s administration has decided not to cover expensive, high-demand obesity treatments under the federal government's Medicare program. The Centers for Medicare and Medicaid ...

Medicare Part D helps roughly 54.8 million of older Americans — nearly 80% of all Medicare enrollees — afford prescription drugs. But rules on what's covered are always changing. Even if have a valid ...